RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Chemotherapy treatment in malignant pleural mesothelioma: A difficult history
2018 Cinausero, Marika; Rihawi, Karim*; Sperandi, Francesca; Melotti, Barbara; Ardizzoni, Andrea
Cisplatin-versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: An individual patient data meta-analysis
2007 Ardizzoni A; Boni L; Tiseo M; Fossella FV; Schiller JH; Paesmans M; Radosavljevic D; Paccagnella A; Zatloukal P; Mazzanti P; Bisset D; Rosell R
Combination of target agents: Challenges and opportunities
2007 Ardizzoni A; Tiseo M
Comparison between epidermal growth factor receptor (EGFR) gene expression in primary non-small cell lung cancer (NSCLC) and in fine-needle aspirates from distant metastatic sites
2008 Bozzetti C; Tiseo M; Lagrasta C; Nizzoli R; Guazzi A; Leonardi F; Gasparro D; Spiritelli E; Rusca M; Carbognani P; Majori M; Franciosi V; Rindi G; Ardizzoni A
Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma
2011 Bozzetti C; Negri FV; Lagrasta CA; Crafa P; Bassano C; Tamagnini I; Gardini G; Nizzoli R; Leonardi F; Gasparro D; Camisa R; Capelli S; Silini EM; Ardizzoni A
Correction to: Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL) (British Journal of Cancer, (2020), 123, 1, (26-32), 10.1038/s41416-020-0845-3)
2021 Gelsomino F.; Tiseo M.; Barbieri F.; Riccardi F.; Cavanna L.; Frassoldati A.; Delmonte A.; Longo L.; Dazzi C.; Cinieri S.; Colantonio I.; Sperandi F.; Lamberti G.; Brocchi S.; Tofani L.; Boni L.; Ardizzoni A.
Current status of second-line treatment and novel therapies for small cell lung cancer
2007 Tiseo M; Ardizzoni A
Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer
2006 Ardizzoni A; Cafferata MA; Tiseo M; Filiberti R; Marroni P; Grossi F; Paganuzzi M
Dramatic responses to therapy in rare tumors
2005 Tiseo M; Monetti E; Ferrarini M; Serrano J; Chiaramondia M; Ardizzoni A
EGFR and EML4-ALK gene mutations in NSCLC: A case report of erlotinilb-resistant patient with both concomitant mutations
2011 Tiseo M; Gelsomino F; Boggiani D; Bortesi B; Bartolotti M; Bozzetti C; Sammarelli G; Thai E; Ardizzoni A
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Chemotherapy treatment in malignant pleural mesothelioma: A difficult history | Cinausero, Marika; Rihawi, Karim*; Sperandi, Francesca; Melotti, Barbara; Ardizzoni, Andrea | 2018-01-01 | JOURNAL OF THORACIC DISEASE | - | 1.04 Replica / breve intervento (e simili) | - |
| Cisplatin-versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: An individual patient data meta-analysis | Ardizzoni A; Boni L; Tiseo M; Fossella FV; Schiller JH; Paesmans M; Radosavljevic D; Paccagnella ...A; Zatloukal P; Mazzanti P; Bisset D; Rosell R | 2007-01-01 | JOURNAL OF THE NATIONAL CANCER INSTITUTE | - | 1.04 Replica / breve intervento (e simili) | - |
| Combination of target agents: Challenges and opportunities | Ardizzoni A; Tiseo M | 2007-01-01 | JOURNAL OF THORACIC ONCOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
| Comparison between epidermal growth factor receptor (EGFR) gene expression in primary non-small cell lung cancer (NSCLC) and in fine-needle aspirates from distant metastatic sites | Bozzetti C; Tiseo M; Lagrasta C; Nizzoli R; Guazzi A; Leonardi F; Gasparro D; Spiritelli E; Rusca... M; Carbognani P; Majori M; Franciosi V; Rindi G; Ardizzoni A | 2008-01-01 | JOURNAL OF THORACIC ONCOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
| Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma | Bozzetti C; Negri FV; Lagrasta CA; Crafa P; Bassano C; Tamagnini I; Gardini G; Nizzoli R; Leonard...i F; Gasparro D; Camisa R; Capelli S; Silini EM; Ardizzoni A | 2011-01-01 | BRITISH JOURNAL OF CANCER | - | 1.04 Replica / breve intervento (e simili) | - |
| Correction to: Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL) (British Journal of Cancer, (2020), 123, 1, (26-32), 10.1038/s41416-020-0845-3) | Gelsomino F.; Tiseo M.; Barbieri F.; Riccardi F.; Cavanna L.; Frassoldati A.; Delmonte A.; Longo ...L.; Dazzi C.; Cinieri S.; Colantonio I.; Sperandi F.; Lamberti G.; Brocchi S.; Tofani L.; Boni L.; Ardizzoni A. | 2021-01-01 | BRITISH JOURNAL OF CANCER | - | 1.04 Replica / breve intervento (e simili) | - |
| Current status of second-line treatment and novel therapies for small cell lung cancer | Tiseo M; Ardizzoni A | 2007-01-01 | JOURNAL OF THORACIC ONCOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
| Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer | Ardizzoni A; Cafferata MA; Tiseo M; Filiberti R; Marroni P; Grossi F; Paganuzzi M | 2006-01-01 | CANCER | - | 1.04 Replica / breve intervento (e simili) | - |
| Dramatic responses to therapy in rare tumors | Tiseo M; Monetti E; Ferrarini M; Serrano J; Chiaramondia M; Ardizzoni A | 2005-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
| EGFR and EML4-ALK gene mutations in NSCLC: A case report of erlotinilb-resistant patient with both concomitant mutations | Tiseo M; Gelsomino F; Boggiani D; Bortesi B; Bartolotti M; Bozzetti C; Sammarelli G; Thai E; Ardi...zzoni A | 2011-01-01 | LUNG CANCER | - | 1.04 Replica / breve intervento (e simili) | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 - Contributo in rivista 69
- 1 - Contributo in rivista::1.04 R... 69
Data di pubblicazione
- 2020 - 2023 2
- 2010 - 2019 17
- 2004 - 2009 50
Rivista
- LUNG CANCER 10
- JOURNAL OF CLINICAL ONCOLOGY 8
- JOURNAL OF THORACIC ONCOLOGY 8
- ANNALS OF ONCOLOGY 5
- BRITISH JOURNAL OF CANCER 5
- CANCER 4
- TUMORI 3
- AMERICAN JOURNAL OF CLINICAL ONCO... 2
- BIOCHEMICAL PHARMACOLOGY 2
- EUROPEAN JOURNAL OF CANCER 2
Keyword
- NSCLC 10
- EGFR 8
- non-small cell lung cancer 8
- gefitinib 7
- cisplatin 5
- breast cancer 4
- chemotherapy 4
- erlotinib 3
- FISH 3
- non small cell lung cancer 3
Lingua
- eng 69
Accesso al fulltext
- no fulltext 69